Skip to main content
Solutions
Nexus IB10 point-of-care technology
Microtiter plate assays
Service Measurements
Science
Critical Care Settings
Acute Care Pathways
Sepsis
COVID-19
Acute Care Biomarkers
penKid - kidney function biomarker
bio-ADM - endothelial function biomarker
DPP3 - cardiac depression factor
Collaborations
Network
Clinical Evaluation
Distribution Partners
Biomarker Out-Licensing
Company
About us
Team
Careers
News
Events
Newsletter
Contact us
Resource Center
Downloads
Scientific Publications
Search
(current)
Order
Contact us
Request a Quote
Newsletter
Reset
179 results:
91.
Adrenomedullin, a circulating biomarker of congestion: in search of evidence
Staszewsky L.
92.
Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission
Pandhi P.
93.
Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
Molvin J.
94.
Bioactive adrenomedullin, organ support therapies, and survival in the critically ill: Results from the French and European Outcome Registry in ICU study
Lemasle L.
95.
Circulating biologically active adrenomedullin predicts organ failure and mortality in sepsis
Kim H.
96.
Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome
Arrigo M.
97.
Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
Takagi K.
98.
Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more
Magliocca A.
99.
A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysate
Kaufmann P.
100.
Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics
Deniau B.
Search results 91 until 100 of 179
previous
5
6
7
8
9
10
11
12
13
14
next